前收市價 | 182.72 |
開市 | 180.21 |
買盤 | 177.42 x 100 |
賣出價 | 178.53 x 100 |
今日波幅 | 174.29 - 181.25 |
52 週波幅 | 93.95 - 191.78 |
成交量 | |
平均成交量 | 296,346 |
市值 | 5.077B |
Beta 值 (5 年,每月) | 0.89 |
市盈率 (最近 12 個月) | 81.18 |
每股盈利 (最近 12 個月) | 2.19 |
業績公佈日 | 2024年8月05日 - 2024年8月09日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 189.00 |
Krystal Biotech shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Krystal Biotech, Inc. (NASDAQ:KRYS) is the premier gene therapy stock for your portfolio. Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease. This approach […]
Novartis (NVS) reports phase III data that confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria.